Damora Therapeutics (DMRA) Net Cash Flow (QoQ) (2020 - 2026)
Damora Therapeutics (DMRA) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45,787.17% |
| Dec 31, 2025 | 122.87% |
| Sep 30, 2025 | -17.30% |
| Jun 30, 2025 | 8.28% |
| Mar 31, 2025 | 50.22% |
| Dec 31, 2024 | -32.43% |
| Sep 30, 2024 | -294.74% |
| Jun 30, 2024 | 860.00% |
| Mar 31, 2024 | 86.72% |
| Dec 31, 2023 | -10,010.53% |
| Sep 30, 2023 | 100.91% |
| Jun 30, 2023 | 72.95% |
| Mar 31, 2023 | -362.54% |
| Dec 31, 2022 | 365.26% |
| Sep 30, 2022 | 92.54% |
| Jun 30, 2022 | 12.43% |
| Mar 31, 2022 | -397.63% |
| Dec 31, 2021 | -61.79% |
| Sep 30, 2021 | 65.06% |
| Jun 30, 2021 | 93.19% |